Vimarsana
Biggest News Aggregation in the World

Page 4 - Hal Paz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hal Paz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hal Paz Today - Breaking & Trending Today

SBU taps top nephrologist as med school dean | Long Island Business News - Vimarsana News

SBU taps top nephrologist as med school dean | Long Island Business News

Dr. Peter Igarashi to lead Renaissance School of Medicine

Source: libn.com
SBU appoints new dean of dental medicine | Long Island Business News - Vimarsana News

SBU appoints new dean of dental medicine | Long Island Business News

Dr. Patrick Lloyd will help the university advance its dental education, research, patient car, and service to the community

Source: libn.com
At Stony Brook University Hospital, a new chief medical officer - Vimarsana News

At Stony Brook University Hospital, a new chief medical officer

Dr. Jonathan Buscaglia will oversee all clinical operations, including the quality of care and patient safety, coordination of clinical care, development of clinical information systems and physician engagement

Source: libn.com
LI employers named to 2022 Healthcare Equality Index | Long Island Business News - Vimarsana News

LI employers named to 2022 Healthcare Equality Index | Long Island Business News

Several Long Island healthcare systems have been named to the 2022 Healthcare Equality Index. These organizations policies and practices related to the equity and inclusion of their LGBTQ+ patients. Among those organizations recognized are Northwell Health, Stony Brook University Medical Center and Northport VA Medical Center. “At Northwell Health we continue to expand our culture ...

Source: libn.com
Lenox Hill lands spot in Healthgrades top 50 hospitals list - Vimarsana News

Lenox Hill lands spot in Healthgrades top 50 hospitals list

Plus: Bristol Myers Squibb notches 8% revenue growth for Q4 Clinical trial startup raises $20M Series A round Regeneron beats Q4 estimates as Covid antibody cocktail drives growth